- Filed
- Feb 11, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Dec 31, 2025 | 6.16M sh |
| Shares Diluted | Q1 2026 · Dec 31, 2024 | 6.02M sh |
| Shares Outstanding | Q1 2026 · Dec 31, 2025 | 6.22M sh |
| Capex | Q1 2026 · Dec 31, 2025 | $96K |
| Capex | Q1 2026 · Dec 31, 2024 | $109K |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $386K |
| Short Term Debt | Q1 2026 · Sep 30, 2025 | $7.97M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $1.11M |
| Cash And Equivalents | Q1 2026 · Sep 30, 2025 | $491K |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $38.7M |
| Stockholders Equity | Q1 2026 · Sep 30, 2025 | $36.89M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $33.68M |
| Stockholders Equity | Q1 2026 · Sep 30, 2024 | $30.43M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $21.99M |
| Current Liabilities | Q1 2026 · Sep 30, 2025 | $22.24M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $37.77M |
| Current Assets | Q1 2026 · Sep 30, 2025 | $35.09M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $74.94M |
| Total Assets | Q1 2026 · Sep 30, 2025 | $73.39M |
| Eps Diluted | Q1 2026 · Dec 31, 2025 | $0.29 |
| Eps Diluted | Q1 2026 · Dec 31, 2024 | −$0.38 |
| Eps Basic | Q1 2026 · Dec 31, 2025 | $0.29 |
| Eps Basic | Q1 2026 · Dec 31, 2024 | −$0.38 |
| Sga Expense | Q1 2026 · Dec 31, 2025 | $2.65M |
| Sga Expense | Q1 2026 · Dec 31, 2024 | $2.84M |
| Net Income | Q1 2026 · Dec 31, 2025 | $1.79M |
| Net Income | Q1 2026 · Dec 31, 2024 | −$2.32M |
| Operating Income | Q1 2026 · Dec 31, 2025 | $2.56M |
| Operating Income | Q1 2026 · Dec 31, 2024 | −$1.91M |
| Gross Profit | Q1 2026 · Dec 31, 2025 | $5.19M |
| Gross Profit | Q1 2026 · Dec 31, 2024 | $928K |
| Cost Of Revenue | Q1 2026 · Dec 31, 2025 | $18.78M |
| Cost Of Revenue | Q1 2026 · Dec 31, 2024 | $19.96M |
| Revenue | Q1 2026 · Dec 31, 2025 | $23.97M |
| Revenue | Q1 2026 · Dec 31, 2024 | $20.88M |